Development and validation of a high-sensitivity assay for measuring p217+tau in plasma.

Gallen Triana-BaltzerSetareh MoughadamRandy SlemmonKristof Van KolenClara TheunisMarc MerckenHartmuth C Kolb

Published in: Alzheimer's & dementia (Amsterdam, Netherlands) (2021)

The assay described here exhibits good technical performance and shows potential as a highly accurate peripheral biomarker for A or T status in AD and cognitively normal subjects.

Keyphrases

high throughput
cognitive decline
high resolution
mild cognitive impairment
cerebrospinal fluid
human health
climate change
chemotherapy induced